Startup Deep Dive : Mamaearth — aimed for $3 billion, listed lower, then crashed and recovered

Honasa Consumer wanted its 2023 initial public offering to value the company near $3 billion. It settled for about $1.3 billion, roughly ₹10,500 crore, after pre-IPO markets cooled — and thirteen months later, one bad quarter erased even more value than that, pushing the maker of Mamaearth to a market capitalisation of around ₹7,721 crore and out of the unicorn club it had joined in 2022.

The same company is worth close to ₹15,634 crore ($1.63 billion) as of 18 September 2026 — comfortably above where it listed. Both the fall and the recovery trace back to the same discovery: a brand built on selling directly to customers online now earns most of its revenue the older way, through distributors, general stores and pharmacies, and the bumpy shift between the two models is what nearly broke it, and what eventually pulled it back.

Quick facts

What they do

Honasa Consumer Limited is the Gurugram-based parent of Mamaearth, the toxin-free personal care brand, along with five sister brands: The Derma Co (dermatologist-backed actives), Aqualogica (hydration-led skincare), BBlunt (hair and salon), Dr Sheth’s (dermatologist-formulated skincare) and Staze (personal hygiene, earlier sold as 9 to 9). Between them, the brands sell skin, hair and baby-care products — face washes, serums, sunscreens, shampoos and baby lotions among them — to Indian consumers, mostly urban, digitally active buyers who wanted “clean label” alternatives to the mass FMCG brands that had dominated Indian bathroom shelves for decades. Mamaearth remains the group’s dominant business: it made up around 80% of Honasa’s revenue in FY23, as reported by TechCrunch’s coverage of the company’s stock market listing.

The origin

The founding insight came from a diaper rash. Ghazal Alagh and Varun Alagh’s newborn son, Agastya, developed eczema, and the couple could not find a skincare product in India that was free of the harsh chemicals they suspected were the cause. They asked relatives and friends travelling abroad to bring back toxin-free brands, an arrangement that was expensive and unreliable, and it became clear to them that an entire category was missing from the Indian market: personal care that was demonstrably free of toxins, priced for ordinary households, as reported by StartupTalky’s account of the founders’ story.

Varun brought nine years of classic FMCG training to the problem. He had been a Business Leadership Trainee at Hindustan Unilever starting in 2007, worked his way up to managing a ₹600 crore business across 29 people and 22 categories as an Area Sales Manager, then moved to Diageo as a senior brand manager on Smirnoff before spending three years at Coca-Cola on brand and customer marketing. Ghazal came from a corporate IT background. In November 2016 the couple put in a combined ₹90 lakh of their own money, added early angel capital, and launched Mamaearth as an online-only baby-care brand, betting that India’s beauty market — long served by a handful of large FMCG houses — had room for a small brand that could talk directly to new parents on the internet.

The struggle years

The company’s growth has not been a straight line. In the year ended March 2021 (FY21), Honasa recorded a net loss of ₹1,332 crore against revenue of just ₹460 crore, by far its worst reported year on paper, even while the brand was scaling fast, as compiled from company filings by screener.in.

It also made an acquisition it later had to write off. Honasa had bought Just4Kids Services, the parent of parenting-content platform Momspresso, hoping the content business would feed customers into its product funnel. The expected synergy never showed up: Momspresso’s performance deteriorated sharply through FY23, and after presenting multiple turnaround scenarios, management concluded there was no credible path to the profitability it had underwritten. Honasa took a ₹136 crore impairment on Momspresso’s goodwill in FY23, which turned a small operating profit of about ₹4 crore into a net loss of ₹151 crore for the year — a write-down large enough to swing the entire year’s result, disclosed just months before the company filed its IPO papers, as reported by Inc42.

The most public near-miss came after the IPO, not before it. In the quarter ended September 2024 (Q2 FY25), Honasa rolled out “Project Neev”, a plan to remove the layer of super-stockists that had carried its offline inventory and replace them with direct distributor relationships in its top 50 cities. The switch required the company to take back and provide for ₹63.51 crore of unsold stock sitting with the old distributor network. Revenue fell 7% year-on-year to ₹461.82 crore, and Honasa posted a net loss of about ₹19 crore — its first loss since listing, reversing a year-ago profit of nearly ₹30 crore — as reported by Business Standard. The stock fell more than 20% in a single session and kept sliding for days afterward.

The turning point

If one event explains both the crisis and the recovery, it is the IPO itself. Through 2023, a valuation near $3 billion had reportedly been discussed for Honasa. By the time the issue opened on 31 October 2023, that ambition had been scaled down: the company priced its shares at ₹308-324, valuing itself at about ₹10,500 crore, and it listed on 7 November 2023 at a market capitalisation of roughly $1.3 billion, as reported by TechCrunch. That was already a step down from the scale of the original plan.

Going public then did something a private capitalisation table never had to: it forced Honasa to show its numbers, brand by brand and quarter by quarter, to public-market analysts instead of the venture investors it had answered to before. What emerged over the following year was a business with a thin adjusted EBITDA margin of about 3% in FY23 despite a healthy 70% gross margin, a single brand carrying roughly 80% of revenue, and an offline expansion still finding its footing. When Project Neev’s costs landed in Q2 FY25, the market’s verdict was severe: Honasa’s market capitalisation fell to about ₹7,721 crore by early December 2024, below the $1 billion mark that had defined its 2022 unicorn status, as reported by the Directors’ Institute. From that low, the stock recovered as the distribution transition stabilised and profit resumed climbing, taking the market capitalisation back up to around ₹15,634 crore ($1.63 billion) by 18 September 2026 (screener.in; stockanalysis.com) — roughly 50% above where the company had listed three years earlier.

The money behind it

Fireside Ventures, a fund built specifically to back Indian consumer brands, was Honasa’s first institutional backer, investing in the seed round in December 2016 when Mamaearth was still an idea for a baby lotion. That early conviction mattered as much as the cheque size: Fireside stayed in through multiple rounds and reportedly still held close to a 10% stake by the time of the IPO.

Sequoia Capital India, later renamed Peak XV Partners, came in through a Series B round in January 2020 and returned as lead investor in a $37.5 million round in December 2021 that valued the company at roughly $1.07-1.2 billion, making Honasa one of India’s youngest unicorns at the time; Peak XV reportedly held close to a 19-20% stake going into the IPO. Belgium’s Sofina led a separate $50 million round in July 2021 that valued the company at about $730 million, bringing in patient, growth-stage capital from outside India.

Individual investors mattered to the brand’s visibility as much as to its balance sheet: actor Shilpa Shetty invested small personal cheques starting in 2018 and returned again in 2022, and became one of Mamaearth’s public faces; other early backers who sold shares in the IPO’s offer-for-sale included Snapdeal’s Kunal Bahl and Rohit Bansal, and the Mariwala family’s Rishabh Mariwala. Reported figures for total private funding raised before the IPO vary — Tracxn puts it near $111 million across eight rounds, while Clay’s compilation counts $139 million across nine rounds — with both trackers agreeing that the bulk of it arrived in the 2020-2021 stretch that took Honasa from a profitable niche brand to a unicorn. The November 2023 IPO itself raised ₹1,701 crore in total: ₹365 crore as a fresh issue into the company and ₹1,336 crore as an offer-for-sale for existing shareholders, after anchor investors alone put in ₹765 crore the day before the issue opened, as reported by Business Today. As of 18 September 2026, Honasa’s market value stands at approximately ₹15,634 crore (screener.in; stockanalysis.com; tickertape.in).

How it makes money

Honasa’s model looks straightforward from the outside: sell personal care products at a premium to mass-market FMCG rivals, at lower distribution and advertising cost because the internet lets a brand reach customers directly. The gross margin bears this out — around 70% in FY23, as reported by TechCrunch, comparable to some of the best-run beauty companies anywhere.

The part people get wrong is the “lower cost” half of that pitch. Digital-first does not mean cheap. Honasa spent about ₹744 crore on advertising and promotion in FY25 alone, against revenue of ₹2,067 crore for the year — a marketing bill equal to roughly 36% of everything the company took in, as reported by Storyboard18. That helps explain why a company with 70% gross margins reported an adjusted EBITDA margin of only around 3% in FY23: most of the gross profit goes straight back into paid search, influencer fees and performance marketing to keep acquiring new customers, because a personal care brand without a decades-old retail shelf presence has to buy its visibility every quarter, not just once.

The other cost line that has bitten Honasa is inventory. Because the company also sells through general trade, modern trade and pharmacy chains, it has to push stock to distributors ahead of demand, and if that stock does not sell through, the company eventually has to take it back or write it down, as happened during Project Neev in FY25. The margin, in other words, does not sit in manufacturing, which Honasa outsources entirely to third-party contract manufacturers, or in logistics; it sits in how efficiently the company turns a rupee of marketing spend, or a rupee of channel inventory, into a repeat customer — and that efficiency is the number that has moved around the most from quarter to quarter.

The numbers

Honasa’s revenue has grown every year since listing, but profit has been far less predictable, swinging on one-off items as much as on the underlying business:

FY25 profit fell 34% year-on-year even as revenue grew 8%, largely because of the Project Neev-related costs taken in the September 2024 quarter and continued heavy marketing spend. FY26 profit nearly tripled as the distribution transition stabilised and the newer brands scaled, per company results compiled by screener.in and Trendlyne.

Where the money comes from

For a company that built its name on being a direct-to-consumer brand, the surprise is how much of Honasa’s revenue no longer comes directly from consumers online. Online channels generated 81.37% of Honasa’s revenue in FY21; by FY23 that had fallen to 59.36%, with the balance coming from general trade, modern trade, pharmacy chains and Honasa’s own BBlunt salons, as reported by The Core’s analysis of the company’s disclosures. TechCrunch separately reported that around the time of the IPO, Honasa’s online sales reached nearly 18,600 pin codes while its offline network already spanned more than 154,000 retail points — and that offline footprint kept growing, crossing 250,000 outlets on an omnichannel basis by FY25, according to D2C Insider Pulse’s reporting on the company’s expansion plans.

The brand mix is similarly concentrated at the top. Mamaearth accounted for roughly 80% of Honasa’s revenue in FY23, per TechCrunch, leaving the newer brands — The Derma Co, Aqualogica, BBlunt and Dr Sheth’s — to make up the rest. Those newer brands, though still a minority of revenue, have been growing faster: the company has said they collectively grew more than 30% year-on-year through FY25, a pace the flagship brand itself has not matched, which is the closest thing Honasa has to a second growth engine if Mamaearth’s own growth keeps slowing.

The risks

Three risks sit at the centre of Honasa’s story, and the company has already lived through a version of each one.

The first is brand concentration. With close to four-fifths of revenue tied to a single brand, any reputational problem, quality complaint or simple loss of fashion around Mamaearth specifically would hit the whole company far harder than it would hit a diversified FMCG major with a dozen equally sized brands.

The second is the channel-inventory risk that Project Neev exposed. Honasa’s own disclosures note that its distribution system carries relatively higher inventory than is typical, because stock sits with super-stockists and distributors ahead of actual retail sales; the company found out in Q2 FY25 that changing this network, even for sound long-term reasons, can force a one-time hit of tens of crores in returns and provisions almost overnight.

The third is margin durability. Honasa’s gross margin is high, but its profit depends on keeping advertising spend, currently equal to more than a third of revenue, under control even as it competes against both legacy FMCG houses like Hindustan Unilever and newer, well-funded challenger brands for the same digital attention. If customer acquisition costs keep rising faster than revenue, the thin margin the company already runs on could compress further rather than improve — the scenario that would matter most for a stock still trading at a rich earnings multiple relative to its profit.

The takeaway

The lesson in Honasa’s decade is not that selling directly to customers was a mistake, or that going public exposed some hidden fraud — nothing in its numbers suggests either. It is that the label a company builds its story around, “digital-first” or “direct-to-consumer,” can stop matching its actual revenue mix long before the market notices, and the gap between the story and the ledger is exactly where the next shock tends to come from. Honasa told a D2C story for years while its channel mix quietly moved the other way; the correction, when it came, showed up as one ugly quarter rather than as a gradual, manageable adjustment. Any founder scaling past their original channel would do well to check, on a fixed schedule, whether the pitch deck’s description of the business still matches where the money is actually coming from — because if it does not, the market will eventually ask that question on its own schedule, not the founder’s.

Frequently asked questions

Who founded Mamaearth and when?

Ghazal Alagh and Varun Alagh founded Mamaearth in November 2016, after struggling to find toxin-free skincare products for their newborn son, Agastya.

Is Honasa Consumer, Mamaearth’s parent, profitable?

Yes, though unevenly. It reported a net profit of ₹111 crore in FY24, ₹73 crore in FY25 (down 34% due to one-off distribution costs), and ₹200 crore in FY26, after loss-making years in FY21 and FY23.

What is Honasa Consumer’s current market value?

About ₹15,634 crore (roughly $1.63 billion) as of 18 September 2026, per screener.in and stockanalysis.com — above its November 2023 listing valuation of around ₹10,500 crore.

Does Mamaearth sell only online?

No. Though it started as an online-only D2C brand, online channels made up under 60% of Honasa’s revenue by FY23, with the rest coming from general trade, modern trade, pharmacies and salons; the company has since expanded to more than 250,000 offline outlets.

What other brands does Honasa Consumer own besides Mamaearth?

The Derma Co, Aqualogica, BBlunt, Dr Sheth’s and Staze, alongside Mamaearth, which remained its largest brand by revenue as of FY23.

Sources

Figures are as of September 2026. Currency converted at $1 ≈ ₹96.0 as of 18 September 2026 (Trading Economics).

• TechCrunch, “Mamaearth parent Honasa’s shares pop in bumpy debut”, November 2023
• Business Today, “Mamaearth IPO allotment announced”, November 2023
• Business Today, “Honasa Consumer raises ₹765 cr from anchor investors ahead of IPO”, October 2023
• Business Standard, “Mamaearth parent Honasa Consumer IPO subscribed nearly 7.6 times”, November 2023
• Entrackr, “Mamaearth-parent Honasa posts ₹1,500 Cr revenue in FY23”, October 2023
• Inc42, “Goodwill impairment hits IPO-bound Mamaearth, posts INR 151 Cr loss in FY23”, 2023
• Entrackr, “MamaEarth-parent Honasa posts ₹1,920 Cr revenue, ₹110 Cr PAT in FY24”, May 2024
• Business Standard, “Mamaearth reports Q2 net loss amid inventory correction”, November 2024
• Business Standard, “Mamaearth hits the floor after reporting net loss of ₹19 cr in Q2”, November 2024
• The Core, “Did Mamaearth’s pre-IPO inventory push mask deeper financial troubles?”, 2024
• Directors’ Institute, “Honasa Consumer loses unicorn status as shares plunge”, December 2024
• India Infoline, “Mamaearth parent Honasa Consumer reports ₹534 crore revenue in Q4 FY25”, 2025
• The Hawk, “Mamaearth parent Honasa Consumer’s profit falls 18 pc in Q4, down 34 pc for full fiscal”, 2025
• Storyboard18, “Mamaearth parent ups marketing spend to ₹744 crore in FY25; eyes ₹5,000 crore ARR milestone”, 2025
• D2C Insider Pulse, “Honasa targets ₹5,500 crore revenue by FY31, bets on omnichannel expansion”, 2025
• StartupTalky, “Varun Alagh: Mamaearth owner biography”, accessed September 2026
• Tracxn, “Mamaearth funding and investors”, accessed September 2026
• Clay, “Mamaearth funding dossier”, accessed September 2026
• Screener.in, “Honasa Consumer Ltd” financial statements and shareholding pattern, accessed September 2026
• StockAnalysis.com, “Honasa Consumer (NSE:HONASA) market cap”, accessed 18 September 2026
• Tickertape.in, “Honasa Consumer Ltd” stock page, accessed 18 September 2026

Found an error? Write to us and we’ll correct it in the open, dated, on the piece.